Impact of Chronic Kidney Disease on the Pharmacodynamic and Pharmacokinetic Effects of Ticagrelor in Patients With Diabetes Mellitus and Coronary Artery Disease
Phase of Trial: Phase IV
Latest Information Update: 21 Mar 2017
At a glance
- Drugs Ticagrelor (Primary)
- Indications Coronary artery disease
- Focus Therapeutic Use
- 15 Mar 2017 Planned End Date changed from 1 Oct 2017 to 1 Apr 2018.
- 15 Mar 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Feb 2018.
- 25 Feb 2016 Status changed from not yet recruiting to recruiting, according to ClinicalTrials.gov record.